2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

Czech version

Authors: Tomáš Freiberger
Published in: AtheroRev 2023; 8(3): 135-144
Category: Guidelines

Sources

Číselná označení citované literatury odkazují na citace v originální verzi aktualizace konsenzu:

Cuchel M, Raal FJ, Hegele RA et al. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance. Eur Heart J 2023; 44(25): 2277–2291. Dostupné z DOI: <https://doi: 10.1093/eurheartj/ehad197>.

Labels

Angiology Diabetology Internal medicine Cardiology General practitioner for adults

Anti-obesity drug with exceptional benefit for preventive cardiology: current results of the SELECT trial

VICTORY project: impact of complex pharmacotherapy on compensation of patients with type 2 diabetes mellitus

Use of a fixed combination of ramipril with rosuvastatin in the management of lipitension: an observational study

Measuring lipoprotein(a) concentrations: what and how do we measure and where do we go from here?

New treatment possibilities of homozygous familial hypercholesterolemia

Additional Cardiovascular Risk in Patients Living with HIV Associated with Antiretroviral Therapy

Šobrův den 2023: lipidová doba postmoderní

Rešerše zajímavých článků ze zahraniční literatury

Article was published in

Athero Review

2023 Issue 3